Rivernorth Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-246,674
| Closed | -$2.49M | – | 798 |
|
|
2022
Q4 | $2.49M | Buy |
246,674
+25,000
| +11% | +$253K | 0.11% | 171 |
|
|
2022
Q3 | $2.2M | Hold |
221,674
| – | – | 0.1% | 204 |
|
|
2022
Q2 | $2.2M | Hold |
221,674
| – | – | 0.09% | 197 |
|
|
2022
Q1 | $2.18M | Sell |
221,674
-3,324
| -1% | -$32.7K | 0.08% | 208 |
|
|
2021
Q4 | $2.21M | Hold |
224,998
| – | – | 0.09% | 180 |
|
|
2021
Q3 | $2.19M | Buy |
+224,998
| New | +$2.19M | 0.12% | 137 |
|